Table 3.
Assay Endpoint1 | Description | Endpoint Classification | AC50 (μM) |
---|---|---|---|
ATG_ERa_TRANS_up | Increase in ER alpha transactivation in HepG2 cells | estrogen receptor alpha | 0.168 |
TOX21_ERa_LUC_BG1_Agonist | Agonism against ER 1 in BG1 cells | estrogen receptor alpha | 0.196 |
ATG_PXR_TRANS_up | Increase in PXR transactivation in HepG2 cells | xenosensor | 0.263 |
OT_ERa_EREGFP_0480 | Increase in ERa fluorescent protein induction in HeLa cells | estrogen receptor alpha | 0.306 |
OT_ERa_EREGFP_0120 | Increase in ERa fluorescent protein induction in HeLa cells | estrogen receptor alpha | 0.317 |
ACEA_T47D_80hr_Positive | Effect on cell growth kinetics in T47D cells | Cell growth regulation | 0.448 |
TOX21_ERa_BLA_Agonist_ratio | Induction of ERa beta lactamase in HEK293T cells | estrogen receptor alpha | 0.520 |
NVS_ENZ_hPI3Ka | Inhibition of human PI3K enzyme activity (cell-free) | Cell growth regulation | 0.572 |
NVS_NR_mERa | Cell-free binding to the mouse estrogen receptor alpha | mouse estrogen receptor liganding | 0.980 |
Tox21_p53_BLA_ratio2 | Activation of p53 signaling pathway in HCT116 cells | cell cycle checkpoint | 1.036 |
NVS_NR_bER | Cell-free binding to the bovine estrogen receptor alpha | bovine estrogen receptor liganding | 1.062 |
NVS_NR_hER | Cell-free binding to the human estrogen receptor alpha | human estrogen receptor liganding | 1.337 |
OT_ER_ERbERb_0480 | Increase in ERb fluorescent protein induction in HeLa cells | estrogen receptor | 1.396 |
OT_ER_ERaERb_0480 | Increase in ERa fluorescent protein induction in HEK293T cells | estrogen receptor | 1.618 |
TOX21_MMP_ratio_down | Decreased membrane potential in HEPG2 cells | mitochondrial depolarization | 2.518 |
NVS_ENZ_oCOX1 | Cell-free enzymatic activity to sheep prostaglandin-endoperoxide synthase 1 | cyclooxygenase-1 activity | 2.770 |
BSK_3C_Proliferation_down | Decrease in proliferation in umbilical vein endothelial cells | Cell growth regulation | 2.900 |
APR_HepG2_p53Act_72h_up | Activation of p53 in HepG2 cells | cell cycle checkpoint | 3.074 |
BSK_3C_Vis_down | Decrease in visual activity in umbilical vein endothelial cells | Cellular health | 3.202 |
ATG_ERE_CIS_up | Increase in ERS1 activation in HepG2 cells | ER steroid hormone activity | 3.625 |
APR_HepG2_MitoticArrest_24h_up | Increase in mitochondrial arrest at 24h in HepG2 cells | Cell growth regulation | 3.760 |
BSK_4H_MCP1_up | CCL2 upregulation in vascular umbilical vein endothelial cells | Inflammatory cytokine signals | 3.765 |
ATG_PXRE_CIS_up | Increase in PXR activation in HepG2 cells | xenosesnor | 4.064 |
OT_ER_ERaERa_0480 | Agonism against ER 1 in HEK293T cells | ER steroid hormone activity | 4.196 |
NVS_NR_hPXR | Inhibition of human PXR binding (cell-free) | xenosensor | 4.256 |
CEETOX_H295R_TESTO_dn | Decreased catalytic activity of testosterone in H295R cells | steroidogenesis | 4.377 |
ATG_DR5_CIS_up | Increase in RAR cis-activation in HepG2 cells | retinoid signaling | 4.386 |
NVS_ADME_hCYP2C9 | Cell-free enzyme activity at human Cyp2C9 | Detoxification/ metabolism | 4.403 |
NHEERL_ZF_144hpf_TERATOSCORE_up | Increase in TERATOSCORE in zebrafish at 144hpf | Abnormal embryo development | 4.440 |
BSK_3C_IL8_up | Increase in IL-8 protein levels in umbilical vein endothelial cells | Inflammatory cytokine signals | 4.528 |
BSK_LPS_IL8_up | CXCL8 downregulation in vascular umbilical vein endothelial cell/peripheral blood mononuclear cell cocultures | Inflammatory cytokine signals | 4.687 |
APR_HepG2_MitoMass_72h_up | Increase in mitochondrial mass in HepG2 cells | mitochondrial number | 4.746 |
BSK_hDFCGF_TIMP1_up | Increase in TIMP metallopeptidase inhibitor protein levels in foreskin fibroblast cells | Extracellular matrix remodelling | 4.754 |
NVS_ENZ_oCOX2 | Inhibition of sheep COX2 enzymatic activity (cell-free) | cyclooxygenase-2 activity | 4.911 |
TOX21_TR_LUC_GH3_Antagonist | Antagonism of thyroid hormone receptor alpha and beta in GH3 cells | Nuclear receptor activity | 5.177 |
NVS_ADME_hCYP2C19 | Inhibition of human CYP2C19 activity (cell-free) | Detoxification/ metabolism | 5.677 |
APR_HepG2_CellCycleArrest_24h_dn | Decrease in cell cycle arrest at 24h in HepG2 cells | Cell growth regulation | 5.946 |
APR_HepG2_CellCycleArrest_72h_dn | Decrease in cell cycle arrest at 72h in HepG2 cells | Cell growth regulation | 6.384 |
BSK_4H_Pselectin_down | Decrease in P-selectin protein levels in umbilical vein endothelial cells | Endothelial cell-related signaling | 6.740 |
APR_HepG2_StressKinase_24h_up | Increase in stress kinase enzyme activity at 24h in HepG2 cells | Cellular stress | 7.050 |
BSK_3C_HLADR_down | Decrease in major histocompatibility complex, class II, DR alpha levels in umbilical vein endothelial cells | Immune function | 7.101 |
APR_HepG2_MitoticArrest_72h_up | Increase in cell cycle arrest in HepG2 cells | Cell growth regulation | 7.368 |
BSK_LPS_CD40_down | Decrease in CD40 (TNF receptor superfamily member 5) in vascular umbilical vein endothelial cell/peripheral blood mononuclear cell cocultures | Immune and inflammatory regulation | 7.566 |
Additional assay information downloadable at https://www3.epa.gov/research/COMPTOX/toxcast_assay.html
Assay run multiple times (5) with consistent results (AC50 range 1.04–3.18 μM)